Articles in the Treatments Category
Resources, Treatments »
| Brand Name: | Sustiva |
| Generic Name: | efavirenz |
| Company: | Bristol-Myers Squibb |
| FDA Clinical Phase: | Capsule formula approved in 1998 in combination with other HIV drugs for the treatment of HIV. Tablet formula approved in 2002 |
Description
Sustiva is a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) approved by the U.S. Food and Drug Administration for HIV-1-positive adults and children older than 3 years of age. For patients beginning antiretroviral…
Resources, Treatments »
| Brand Name: | Invirase |
| Generic Name: | saquinavir mesylate |
| Company: | Hoffman-La Roche |
| FDA Clinical Phase: | Approved in 1995 for the treatment of HIV-1 infection |
Description
Invirase (saquinavir mesylate) is part of a class of anti-HIV drugs known as Protease Inhibitors (PIs). By inhibiting the action of protease, an enzyme, Invirase ensures that replicated viruses cannot infect other CD4 cells. CD4 cells, also known…
Resources, Treatments »
| Brand Name: | Fuzeon |
| Generic Name: | enfuvirtide |
| Company: | Hoffmann-La Roche Inc. (Roche Pharmaceuticals) |
| FDA Clinical Phase: | Approved for use in 2003 in combination with other HIV drugs to increase CD4 cell count (“helper T-cells”) and decrease viral load (number of HIV copies in a blood sample). |
Description
Fuzeon is the first fusion inhibitor approved by the U.S. Food and Drug Administration for patients who…